Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.67
-0.07 (-0.65%)
At close: Mar 6, 2026, 4:00 PM EST
10.46
-0.21 (-1.97%)
After-hours: Mar 6, 2026, 7:39 PM EST
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $840.78 million as of March 6, 2026. Its market cap has increased by 121.95% in one year.
Market Cap
840.78M
Enterprise Value
1.30B
1-Year Change
121.95%
Ranking
Category
Stock Price
$10.67
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $840.78M, an increase of 59.50%. That is a compound annual growth rate of 7.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 871.23M |
| Arvinas | 869.87M |
| Janux Therapeutics | 841.91M |
| Sana Biotechnology | 840.63M |
| Evommune | 835.39M |
| BridgeBio Oncology Therapeutics | 833.94M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |